Attached files
| file | filename |
|---|---|
| S-1/A - AMENDMENT NO. 4 TO FORM S-1 - ARGOS THERAPEUTICS INC | d214145ds1a.htm |
| EX-10.8 - 2011 STOCK INCENTIVE PLAN - ARGOS THERAPEUTICS INC | d214145dex108.htm |
| EX-24.2 - POWER OF ATTORNEY (DAVID W. GRYSKA) - ARGOS THERAPEUTICS INC | d214145dex242.htm |
| EX-10.15 - FORM OF INDEMNIFICATION AGREEMENT - ARGOS THERAPEUTICS INC | d214145dex1015.htm |
| EX-10.20 - LICENSE AGREEMENT - GERON CORPORATION - ARGOS THERAPEUTICS INC | d214145dex1020.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the use in this Registration Statement on Form S-1/A of Argos Therapeutics, Inc. of our report dated February 10, 2012 relating to the financial statements, which appears in such Registration Statement. We also consent to the references to us under the heading “Experts” in such Registration Statement.
/s/ PricewaterhouseCoopers LLP
Raleigh, North Carolina
February 10, 2012